Preclinical models are research tools used to test new treatments before trying them ... single behaviour is guaranteed to prevent dementia - but there's lots of evidence to suggest that making ...
A groundbreaking discovery by scientists at Japan’s RIKEN Center for Brain Science has revealed an unexpected link between dopamine and Alzheimer’s disease. This revelation could mark a major ...
Kathy Ingebrand was diagnosed with Alzheimer's at 59 years old. "This patient is receiving a treatment ... her insurance will cover the cost. There are possible side effects, Bazakos said ...
China's medical regulator has approved Eli Lilly's treatment for early Alzheimer's, providing patients with another option after Eisai and Biogen's Leqembi received approval in January ...
(“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson's disease ...
Former study was recently accepted in a peer-reviewed medical journal with focus on Alzheimer’s disease titled, “Blarcamesine for the treatment ... efficacy or safety. There is no guarantee ...